Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Tablets × CNS × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 Other hematologic neoplasm 3 Other solid neoplasm 2 Other 2 Head & Neck 2 Gynecologic 2 Gastrointestinal 2 Thoracic 1 Plasma cell 1 Lymphoid 1 Genitourinary 1 CNS 1

Conditions

Interventions

Temozolomide 61 Magnetic Resonance Spectroscopy 56 Specimen Handling 36 Radiotherapy 35 Radiosurgery 30 Cyclophosphamide 22 Bevacizumab 22 pembrolizumab 19 Radiation 14 Blood Specimen Collection 14 fludarabine 12 Irinotecan 12 Pemetrexed 11 Lomustine 11 Nivolumab 10 Etoposide 10 Carboplatin 10 Biopsy 10 Vincristine 9 trametinib 8 lutetium Lu 177 dotatate 8 Surgical Procedures, Operative 8 Fluorodeoxyglucose F18 8 naxitamab 7 fluciclovine F-18 7 Everolimus 7 Drug Therapy 7 olaparib 6 gallium Ga 68 dotatate 6 dinutuximab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06275919 2025-03-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡